Prof. RNDr. Viktor BRABEC, DrSc.

Avatar
Contact

585634154, 607824450

Katedra biofyziky

Přírodovědecká fakulta

Šlechtitelů 27 - objekt 49 (C)

1.13A

profesor

molecular biophysics and pharmacology, structure and interactions of nucleic acids, structure-pharmacological activity relationship of antitumor compounds

ČLÁNEK
Hernández-García A., Marková L., Santana MD., Prachařová J., Bautista D., Kostrhunová H., Novohradský V., Brabec V., Ruiz J., Kašpárková J. Cyclometalated Benzimidazole Osmium(II) Complexes with Antiproliferative Activity in Cancer Cells Disrupt Calcium Homeostasis. INORGANIC CHEMISTRY. 2023.
Bresciani G., Červinka J., Kostrhunová H., Biancalana L., Bortoluzzi M., Pampaloni G., Novohradský V., Brabec V., Marchetti F., Kašpárková J. N-Indolyl diiron vinyliminium complexes exhibit antiproliferative effects in cancer cells associated with disruption of mitochondrial homeostasis, ROS scavenging, and antioxidant activity. CHEMICO-BIOLOGICAL INTERACTIONS. 2023.
Schleser SW., Krytovych O., Ziegelmeier T., Gross E., Kašpárková J., Brabec V., Weber T., Schobert R., Mueller T. Palladium and Platinum Complexes of the Antimetabolite Fludarabine with Vastly Enhanced Selectivity for Tumour over Non-Malignant Cells. MOLECULES. 2023.
Prachařová J., Kostrhunová H., Barbanente A., Margiotta N., Brabec V. The mechanism of antiproliferative activity of the oxaliplatin pyrophosphate derivative involves its binding to nuclear DNA in cancer cells. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY. 2023.
Schmidt C., Babu T., Kostrhunová H., Brabec V. Are Pt(IV) prodrugs that release combretastatin A4 true multi-action prodrugs? JOURNAL OF MEDICINAL CHEMISTRY. 2021.
Masaryk L., Nemec I., Kašpárková J., Brabec V., Štarha P. Unexpected solution behaviour of ester-functionalized half-sandwich Ru(II) and Ir(III) complexes. Dalton Transactions. 2021.
Nunhart P., Konkolova E., Janovec L., Kašpárková J., Malina J., Brabec V. Antimicrobial activity and DNA/HSA interaction of fluorinated 3,6,9-trisubstituted acridines. CHEMICAL PAPERS. 2020.
Crlíková H., Kostrhunová H., Prachařová J., Kozsup M., Nagy S., Buglyó P., Brabec V., Kašpárková J. Antiproliferative, DNA binding, and cleavage properties of dinuclear Co(III) complexes containing the bioactive quinizarin ligand. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY. 2020.
Nagy I., Farkas ER., Kašpárková J., Kostrhunová H., Brabec V., Buglyó P. Synthesis and characterization of (Ru(II), Co(III)) heterobimetallic complexes formed with a 1,10-phenanthroline based hydroxamic acid conjugate. JOURNAL OF ORGANOMETALLIC CHEMISTRY. 2020.
Novohradský V., Marková L., Kostrhunová H., Trávníček Z., Brabec V., Kašpárková J. An anticancer Os(II) bathophenanthroline complex as a human breast cancer stem cell selective, mammosphere potent agent that kills cells by necroptosis. Scientific Reports. 2019.
Hreusová M., Nováková O., Kostrhunová H., Prachařová J., Brabec V., Kašpárková J. DNA modification by cisplatin-like Pt(II) complexes containing 1,1′-binaphtyl-2,2′-diamine ligand does not correlate with their antiproliferative activity in cancer cells. INORGANICA CHIMICA ACTA. 2019.
Janočková J., Korábečný J., Plšíková J., Kašpárková J., Brabec V. In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2019.
Chen F., Soldevila-Barreda J., Romero-Canelón I., Coverdale J., Song J., Clarkson G., Kašpárková J., Habtemariam A., Brabec V., Wolny J., Schünemann V., Sadler P. Effect of sulfonamidoethylenediamine substituents in Ru-II arene anticancer catalysts on transfer hydrogenation of coenzyme NAD( ) by formate. DALTON TRANSACTIONS. 2018.
Intini FP., Zajac J., Novohradský V., Saltarella T., Pacifico C., Brabec V., Natile G., Kašpárková J. Novel Antitumor Platinum(II) Conjugates Containing the Nonsteroidal Anti-inflammatory Agent Diclofenac: Synthesis and Dual Mechanisms of Antiproliferative Effects. Inorganic Chemistry. 2017.
Perfahl S., Bodtke A., Prachařová J., Kašpárková J., Brabec V., Cuadrado J., Sturup S., Schulzke C., Bednarski PJ. Preparation of bis(5-phenyltetrazolato) Pt(II) and Pt(IV) analogues of transplatin and in vitro evaluation for antitumor activity. Inorganica Chimica Acta. 2017.
Bečka M., Vilková M., Salem OM., Kašpárková J., Brabec V., Kožurková M. 3-[(E)-(acridin-9 '-ylmethylidene)amino]-1-substituted thioureas and their biological activity. Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy. 2017.
Janočková J., Zilecká E., Kašpárková J., Brabec V., Soukup O., Kuča K., Kožurková M. Assessment of DNA-binding affinity of cholinesterase reactivators and electrophoretic determination of their effect on topoisomerase I and II activity. Molecular BioSystems. 2016.
Muenzer J., Biersack B., Albrecht A., Rehm T., Lacher U., Milius W., Casini A., Zhang J., Ott I., Brabec V., Stuchlíková O., Andronachte I., Schuppan D., Kaps L., Schobert R. Ferrocenyl-Coupled N-Heterocyclic Carbene Complexes of Gold(I): A Successful Approach to Multinuclear Anticancer Drugs. Chemistry: A European Journal. 2016.
Yellol J., Perez S., Yellol G., Zajac J., Donaire A., Novohradský V., Janiak C., Brabec V., Ruiz J. Highly potent extranuclear-targeted luminescent iridium(III) antitumor agents containing benzimidazole-based ligands with a handle for functionalization. Chemical Communications. 2016.
Salem OM., Vilková M., Janočková J., Jendželovský R., Fedoročko P., Zilecká E., Kašpárková J., Brabec V., Imrich J., Kožurková M. New spiro tria(thia)zolidine-acridines as topoisomerase inhibitors, DNA binders and cytostatic compounds. International Journal of Biological Macromolecules. 2016.
Kašpárková J., Kostrhunová H., Nováková O., Křikavová R., Vančo J., Trávníček Z., Brabec V. A Photoactivatable Platinum(IV) Complex Targeting Genomic DNA and Histone Deacetylases. Angewandte Chemie - International Edition. 2015.
Janočková .., Plšíková J., Kašpárková J., Brabec V., Jendželovský R., Mikeš J., Koval J., Hamuľ áková S., Fedoročko P., Kuča K., Kožurková M. Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compounds. European Journal of Pharmaceutical Sciences. 2015.
Prachařová J., Saltarella .., Radošová Muchová T., Scintilla S., Novohradský V., Nováková O., Intini FP., Pacifico C., Natile G., Ilík P., Brabec V., Kašpárková J. Novel antitumor cisplatin and transplatin derivatives containing 1-methyl-7-azaindole: Synthesis, characterization, and cellular responses. Journal of Medicinal Chemistry. 2015.
Novohradský V., Zhe L., Vojtíšková M., Sadler PJ., Brabec V., Kašpárková J. Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand. Metallomics. 2014.
Frýbortová M., Nováková O., Brabec V. The stability of DNA intrastrand cross-links of antitumor transplatin derivative containing non-bulky methylamine ligands. Journal of Biological Inorganic Chemistry. 2014.
Frýbortová M., Nováková O., Štěpánková J., Novohradský V., Gibson D., Kašpárková J., Brabec V. Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand. Journal of Inorganic Biochemistry. 2013.
Zhao Y., Woods JA., Farrer NJ., Robinson KS., Prachařová J., Kašpárková J., Nováková O., Li H., Salassa L., Pizarro AM., Clarkson GJ., Song L., Brabec V., Sadler PJ. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts. Chemistry: A European Journal. 2013.
Muchová T., Quintal SM., Farrell N., Brabec V., Kašpárková J. Antitumor bifunctional dinuclear Pt-II complex BBR3535 forms interduplex DNA cross-links under molecular crowding conditions. Journal of Biological Inorganic Chemistry. 2012.
Suchánková T., Kubíček K., Kašpárková J., Brabec V., Kozelka J. Platinum-DNA interstrand crosslinks: Molecular determinants of bending and unwinding of the double helix. Journal of Inorganic Biochemistry. 2012.
Kisová A., Zerzánková L., Habtemariam A., Sadler PJ., BRABEC V., Kašpárková J. Differences in the cellular response and signaling pathways between cisplatin and monodentate organometallic Ru(II) antitumor complexes containing a terphenyl ligand. Molecular Pharmaceutics. 2011.
Zerzánková L., Suchánková T., Vrána O., Farrell N., Brabec V., Kašpárková J. Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles. Biochemical Pharmacology. 2010.
Nováková O., Malina J., Kašpárková J., Halámiková A., Bernard V., Intini F., Natile G., Brabec V. Energetics, conformation, and recognition of DNA duplexes modified by methylated analogues of [PtCl(dien)]+. Chem Eur J, 15, 6211-6221. Chemistry: A European Journal. 2009.
Ruhayel R.A.., Moniodis J.J.., Yang X., Kašpárková J., Brabec V., Bernes-Price S., Farrell N. Factors affecting DNA-DNA interstrand cross-links in the antiparallel 3'-3' sense: A comparison with the 5'-5' directional isomer. Chemistry: A European Journal. 2009.
Mašek V., Anzenbacherová E., Machová M., Brabec V., Anzenbacher P. Interaction of antitumor platinum complexes with human liver microsomal cytochromes P450. Anti-cancer Drugs. 2009.
Castellano-Castillo M., Kostrhunová H., Marini V., Kašpárková J., Sadler P., Malinge J., Brabec V. Binding of mismatch repair protein MutS to mispaired DNA adducts of intercalating ruthenium(II) arene complexes. Journal of Biological Inorganic Chemistry. 2008.
Kašpárková J., Marini V., Bursová V., Brabec V. Biophysical Studies on the stability of DNA intrastrand cross-links of transplatin. Biophysical Journal. 2008.
Bugarcic T., Nováková O., Halámiková A., Zerzánková L., Vrána O., Kašpárková J., Habtemariam A., Pardone S., Sadler P., Brabec V. Cytotoxicity, cellular uptake, and DNA interactions of new monodentate ruthenium(II) complexes containing terphenyl arenes. Journal of Medicinal Chemistry. 2008.
Bugarcic T., Habtemariam A., Štěpánková J., Heringová P., Kašpárková J., Deeth J.R.., Johnstone R.D.L., Prescimone A.., Parsons S.., Parkin A.., Brabec V., Sadler P. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes. Inorganic Chemistry. 2008.
KAPITOLA V KNIZE
Brabec V., Kašpárková J. Role of DNA repair in antitumor effects of platinum drugs. Metal Complex - DNA Interactions. 2009.
ABSTRAKT
Brabec V., Prachařová J., Kašpárková J., Sadler PJ. Interactions of DNA with a New Platinum(IV) Azide Dipyridine Complex Activated by UVA and Visible Light: Relationship to Toxicity in Tumor Cells. Journal of Biological Inorganic Chemistry. 2014.
Kašpárková J., Mlčoušková J., Brabec V. Light-potentiated Cytotoxicity of Carboplatin in Tumor Cells: Enhanced DNA Binding. Journal of Biological Inorganic Chemistry. 2014.

Uživatel nepovolil zobrazení dat v Portále UP.

Doctoral study on UP

Name Faculty Study programme Year of completion
ZAJAC PRF Fyzika 2017
MLČOUŠKOVÁ PRF Fyzika 2012
HREUSOVÁ PRF Fyzika 2021
MUCHOVÁ PRF Fyzika 2013
OLIVOVÁ PRF Fyzika 2013
FRÝBORTOVÁ PRF Fyzika 2014
List contains doctoral study graduates

Privacy settings

We use cookies and any other network identifiers on our website that may contain personal data (e.g. about how you browse our website). We and some of the service providers we use have access to or store this data on your device. This data helps us to operate and improve our services. For some purposes, your consent is required to process data collected in this way. You can change or revoke your consent at any time (see the link at the bottom the page).

(Essential cookies enable basic functions and are necessary for the website to function properly.)
(Statistics cookies collect information anonymously. This information helps us to understand how our visitors use our website.)
(They are designed for promotional purposes, measuring the success of promotional campaigns, etc.)